Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Sara C. Keller is active.

Publication


Featured researches published by Sara C. Keller.


Hispanic Health Care International | 2010

Perceived Discrimination and Use of Health Care Services in a North Carolina Population of Latino Immigrants

Sara C. Keller; Mina Silberberg; Katherine E Hartmann; J. Lloyd Michener

ealth care utilization among Latinos in the United States is low. Nationwide, only 55% had seen a physician in the past year, compared with 73% of non-Latino whites ( Ezzati-Rice, Kasjijara, & Machlin, 2004 ). Thus, identifying and removing barriers to care in this population is essential. Barriers that Latinos face to health care access include culture and language differences, immigration status, and inadequate insurance


Clinical Infectious Diseases | 2018

Rates of and Risk Factors for Adverse Drug Events in Outpatient Parenteral Antimicrobial Therapy

Sara C. Keller; Deborah Williams; Mitra Gavgani; David Hirsch; John Adamovich; Dawn Hohl; Ayse P. Gurses; Sara E. Cosgrove

BackgroundnTo better monitor patients on outpatient parenteral antimicrobial therapy (OPAT), we need an improved understanding of risk factors for and timing of OPAT-associated adverse drug events (ADEs).nnnMethodsnWe analyzed a prospective cohort of patients on OPAT discharged from 2 academic medical centers. Patients underwent chart abstraction and a telephone survey. Multivariable analyses estimated adjusted incident rate ratios (aIRR) between clinical and demographic risk factors and clinician-determined clinically significant ADEs. Descriptive data were used to present patient-reported ADEs.nnnResultsnOf 339 patients enrolled in the study, 18.0% experienced an ADE (N = 65), of which 49 were significant (14.5%, 2.24/1000 home-OPAT days). Patients with longer courses of therapy had lower rates of ADEs compared with patients treated for 0-13 days (14-27 days: aIRR, 0.44; 95% confidence interval [CI], 0.20-0.99; at least 28 days: aIRR, 0.11; 95% CI, 0.056-0.21). Risk factors for ADEs included female gender and receipt of daptomycin or vancomycin, while treatment for uncomplicated bacteremia and empiric treatment were associated with lower rates of ADEs.nnnConclusionsnOPAT-related ADEs were common and often occurred within 2 weeks of hospital discharge. Patients on OPAT should be monitored more closely for ADEs, including clinical assessment and laboratory monitoring, especially within the first weeks after hospital discharge and particularly among women and patients who receive vancomycin.


Infection Control and Hospital Epidemiology | 2017

Environmental Exposures and the Risk of Central Venous Catheter Complications and Readmissions in Home Infusion Therapy Patients

Sara C. Keller; Deborah Williams; Mitra Gavgani; David Hirsch; John Adamovich; Dawn Hohl; Amanda Krosche; Sara E. Cosgrove; Trish M. Perl

BACKGROUND Patients are frequently discharged with central venous catheters (CVCs) for home infusion therapy. OBJECTIVE To study a prospective cohort of patients receiving home infusion therapy to identify environmental and other risk factors for complications. DESIGN Prospective cohort study between March and December 2015. SETTING Home infusion therapy after discharge from academic medical centers. PARTICIPANTS Of 368 eligible patients discharged from 2 academic hospitals to home with peripherally inserted central catheters and tunneled CVCs, 222 consented. Patients remained in the study until 30 days after CVC removal. METHODS Patients underwent chart abstraction and monthly telephone surveys while the CVC was in place, focusing on complications and environmental exposures. Multivariable analyses estimated adjusted odds ratios and adjusted incident rate ratios between clinical, demographic, and environmental risk factors and 30-day readmissions or CVC complications. RESULTS Of 222 patients, total parenteral nutrition was associated with increased 30-day readmissions (adjusted odds ratio, 4.80 [95% CI, 1.51-15.21) and CVC complications (adjusted odds ratio, 2.41 [95% CI, 1.09-5.33]). Exposure to soil through gardening or yard work was associated with a decreased likelihood of readmissions (adjusted odds ratio, 0.09 [95% CI, 0.01-0.74]). Other environmental exposures were not associated with CVC complications. CONCLUSIONS complications and readmissions were common and associated with the use of total parenteral nutrition. Common environmental exposures (well water, cooking with raw meat, or pets) did not increase the rate of CVC complications, whereas soil exposures were associated with decreased readmissions. Interventions to decrease home CVC complications should focus on total parenteral nutrition patients. Infect Control Hosp Epidemiol 2016;1-8.


Open Forum Infectious Diseases | 2016

Role of Suppressive Oral Antibiotics in Orthopedic Hardware Infections for Those Not Undergoing Two-Stage Replacement Surgery

Sara C. Keller; Sara E. Cosgrove; Yvonne Higgins; Damani A. Piggott; Greg Osgood; Paul G. Auwaerter

Suppressive oral antibiotics for at least three months, but not at least six months, are associated with treatment success at one year post-diagnosis of orthopedic hardware infection.


JAMA Internal Medicine | 2017

An Implementation Guide to Reducing Overtreatment of Asymptomatic Bacteriuria

Michael Daniel; Sara C. Keller; Mohammad Mozafarihashjin; Amit K. Pahwa; Christine Soong

Treatment of asymptomatic bacteriuria (ASB) frequently lacks appropriate indication, yet remains prevalent across settings. Numerous guidelines, professional societies, and campaigns such as Choosing Wisely advocate against this low-value practice. Efforts aimed at reducing unnecessary treatment of ASB demonstrate improved costs, and avoidable harm without increased risk of adverse events. We propose an evidence-based implementation guide to aid practitioners in reducing inappropriate treatment of ASB.


American Journal of Infection Control | 2014

Catheter-Salvage in Home Infusion Patients with Central Line-Associated Bloodstream Infection

Daniel A. Caroff; Anne Norris; Sara C. Keller; Christopher Vinnard; Kristen Zeitler; Jennifer Lukaszewicz; Kristine A. Zborowski; Darren R. Linkin

In a retrospective study of home infusion patients with central line-associated bloodstream infection, use of a central venous port, cancer diagnosis, and absence of systemic inflammatory response syndrome were associated with use of catheter salvage. Relapse of infection was uncommon.


Pharmacotherapy | 2018

Antimicrobial Agents and Catheter Complications in Outpatient Parenteral Antimicrobial Therapy

Sara C. Keller; Kathryn Dzintars; Lisa A. Gorski; Deborah Williams; Sara E. Cosgrove

Debate about whether certain antimicrobial agents traditionally considered vesicants increase the risk of catheter complications has led to uncertainty in venous catheter placement protocols. To understand whether patients requiring home‐based outpatient parenteral antimicrobial therapy (OPAT) should receive peripheral catheters (e.g., midline catheters) versus central venous catheters, and to understand whether certain antimicrobial agents place home‐based OPAT patients at higher risk for catheter complications, we investigated associations between antimicrobial agent(s) and catheter complications.


Open Forum Infectious Diseases | 2018

Health-Related Quality of Life in Outpatient Parenteral Antimicrobial Therapy

Sara C. Keller; Deborah Williams; Mayo Levering; Sara E. Cosgrove

Abstract Health-related quality of life (HRQoL) in outpatient parenteral antimicrobial therapy (OPAT) has not been well characterized in the United States. In an OPAT cohort, the short-form-12’s median physical component score and mental component score were 40.3 and 54.4, respectively. HRQoL measures could be helpful in studies of OPAT cost-effectiveness.


Open Forum Infectious Diseases | 2018

Outpatient parenteral therapy for complicated Staphylococcus aureus infections: a snapshot of processes and outcomes in the real world

Jennifer Townsend; Sara C. Keller; Martin Tibuakuu; Sameer Thakker; Bailey Webster; Maya Siegel; Kevin J. Psoter; Omar Mansour; Trish M. Perl

Abstract Background In the United States, patients discharged on outpatient parenteral antimicrobial therapy (OPAT) are often treated by home health companies (HHCs) or skilled nursing facilities (SNFs). Little is known about differences in processes and outcomes between these sites of care. Methods We performed a retrospective study of 107 patients with complicated Staphylococcus aureus infections discharged on OPAT from 2 academic medical centers. Clinical characteristics, site of posthospital care, process measures (lab test monitoring, clinic follow-up), adverse events (adverse drug events, Clostridium difficile infection, line events), and clinical outcomes at 90 days (cure, relapse, hospital readmission) were collected. Comparisons between HHCs and SNFs were conducted. Results Overall, 33% of patients experienced an adverse event during OPAT, and 64% were readmitted at 90 days. Labs were received for 44% of patients in SNFs and 56% of patients in HHCs. At 90 days after discharge, a higher proportion of patients discharged to an SNF were lost to follow-up (17% vs 3%; P = .03) and had line-related adverse events (18% vs 2%; P < .01). Patients discharged to both sites of care experienced similar clinical outcomes, with favorable outcomes occurring in 61% of SNF patients and 70% of HHC patients at 90 days. There were no differences in rates of relapse, readmission, or mortality. Conclusions Patients discharged to SNFs may be at higher risk for line events than patients discharged to HHCs. Efforts should be made to strengthen basic OPAT processes, such as lab monitoring and clinic follow-up, at both sites of care.


Journal of the American Board of Family Medicine | 2018

Ambulatory Antibiotic Stewardship through a Human Factors Engineering Approach: A Systematic Review

Sara C. Keller; Pranita D. Tamma; Sara E. Cosgrove; Melissa A. Miller; Heather F. Sateia; Julie Szymczak; Ayse P. Gurses; Jeffrey A. Linder

Introduction: In the United States, most antibiotics are prescribed in ambulatory settings. Human factors engineering, which explores interactions between people and the place where they work, has successfully improved quality of care. However, human factors engineering models have not been explored to frame what is known about ambulatory antibiotic stewardship (AS) interventions and barriers and facilitators to their implementation. Methods: We conducted a systematic review and searched OVID MEDLINE, Embase, Scopus, Web of Science, and CINAHL to identify controlled interventions and qualitative studies of ambulatory AS and determine whether and how they incorporated principles from a human factors engineering model, the Systems Engineering Initiative for Patient Safety 2.0 model. This model describes how a work system (ambulatory clinic) contributes to a process (antibiotic prescribing) that leads to outcomes. The work system consists of 5 components, tools and technology, organization, person, tasks, and environment, within an external environment. Results: Of 1,288 abstracts initially identified, 42 quantitative studies and 17 qualitative studies met inclusion criteria. Effective interventions focused on tools and technology (eg, clinical decision support and point-of-care testing), the person (eg, clinician education), organization (eg, audit and feedback and academic detailing), tasks (eg, delayed antibiotic prescribing), the environment (eg, commitment posters), and the external environment (media campaigns). Studies have not focused on clinic-wide approaches to AS. Conclusions: A human factors engineering approach suggests that investigating the role of the clinics processes or physical layout or external pressures role in antibiotic prescribing may be a promising way to improve ambulatory AS.

Collaboration


Dive into the Sara C. Keller's collaboration.

Top Co-Authors

Avatar

Sara E. Cosgrove

Johns Hopkins University School of Medicine

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Ayse P. Gurses

Johns Hopkins University

View shared research outputs
Top Co-Authors

Avatar

David Hirsch

Massachusetts Institute of Technology

View shared research outputs
Top Co-Authors

Avatar

Mitra Gavgani

Johns Hopkins University

View shared research outputs
Top Co-Authors

Avatar

Clare Rock

Johns Hopkins University School of Medicine

View shared research outputs
Top Co-Authors

Avatar

Dawn Hohl

Johns Hopkins University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

John Adamovich

Johns Hopkins University

View shared research outputs
Top Co-Authors

Avatar

Amit Pahwa

Johns Hopkins University School of Medicine

View shared research outputs
Researchain Logo
Decentralizing Knowledge